Allogeneic Hematopoietic Cell Transplantation Outcomes After Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma (CA209-039 and CheckMate 205)

View/Open

Supporting information (63.31Kb)

Publication Date

2017-09-01

ICR Author

Marsden,

Cunningham, David

Author

Carlo-Stella, C

Collins, GP

Armand, P

Zinzani, PL

Cohen, JB

Halwani, A

Millenson, M

Provencio, M

Domingo Domenech, E

Giulino-Roth, L

Castagna, L

Kato, K

McKiver, MP

Sumbul, A

Zhu, L

Trneny, M

Minnema, MC

Rueda, A

Cunningham, D

Reddy, N

Younes, A

Santoro, A

Type

Journal Article

Metadata

Show full item record

URL

https://repository.icr.ac.uk/handle/internal/1379

Collections

• Clinical Studies

Version of record

10.1016/j.clml.2017.07.136

Subject

Science & Technology

Life Sciences & Biomedicine

Oncology

Hematology

Research team

Medicine (RMH Smith Cunningham)

Language

English

License start date

2017-09-01

Citation

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 pp. S326 - S327 (2)

Publisher

CIG MEDIA GROUP, LP